Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hae-Ri Song"'
Autor:
N Sumru Bayin, Aram S Modrek, August Dietrich, Jonathan Lebowitz, Tobias Abel, Hae-Ri Song, Markus Schober, David Zagzag, Christian J Buchholz, Moses V Chao, Dimitris G Placantonakis
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e116114 (2014)
Glioblastoma multiforme (GBM) is a deadly primary brain malignancy. Glioblastoma stem cells (GSC), which have the ability to self-renew and differentiate into tumor lineages, are believed to cause tumor recurrence due to their resistance to current t
Externí odkaz:
https://doaj.org/article/28453f8fe62d44409f698e651ef8e9cb
Autor:
Hae-Ri Song, Myung-Hee Kim
Publikováno v:
Korean Journal of Sociology. 56:103-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b4fcf428a2c9e4c628f6ee11b12a7d3
https://doi.org/10.21562/kjs.2022.11.56.4.103
https://doi.org/10.21562/kjs.2022.11.56.4.103
The NFIA transcription factor is a glioma tumor promoter. The mechanism by which NFIA regulates glioma cell survival and drug resistance is unknown. Here we report that the NFIA pro-survival effect is mediated via an NFIA-NFκB p65 feedforward loop.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb9d80223a19407432404ad8a5f4e67f
https://europepmc.org/articles/PMC5692107/
https://europepmc.org/articles/PMC5692107/
Publikováno v:
Neuro-Oncology. 20:vi32-vi32
Paraoxonase-2 (PON2), a member of paraoxonase family, is an anti-oxidant enzyme that is implicated in cell survival. Recent evidence demonstrated that PON2 promotes apoptosis resistance in the selective tumor cells. Here, we report genetic regulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53d200c88321fda4f90b8721ff4dc5da
https://doi.org/10.1093/neuonc/noy148.120
https://doi.org/10.1093/neuonc/noy148.120
Autor:
Deborah L. Commins, Anat Erdreich-Epstein, Hae-Ri Song, Floyd H. Gilles, Richard Sposto, Greg S. Suh, Ignacio Gonzalez-Gomez, Benjamin Deneen
Publikováno v:
Neuro-Oncology. 12:122-132
Nuclear factor IA (NFIA) is a transcription factor that specifies glial cell identity and promotes astrocyte differentiation during embryonic development. Its expression and function in gliomas are not known. Here, we examined NFIA protein expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::009934dd9a056882560075f31c20bdb6
https://doi.org/10.1093/neuonc/nop044
https://doi.org/10.1093/neuonc/nop044
The Nuclear Factor I-A (NFIA) transcription factor was recently identified as a glioma tumor promoter. We previously reported that NFIA inhibits chemotherapy-induced apoptosis glioblastoma (GBM) cells. However, the mechanism by which the NFIA regulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1620fd2a7a75d818794da2819f68a45
https://europepmc.org/articles/PMC4638681/
https://europepmc.org/articles/PMC4638681/
Publikováno v:
Neuro-Oncology. 19:iv4-iv4
The Nuclear Factor I-A (NFIA) transcription factor is a glioma tumor promoter. However, the mechanism by which NFIA regulates glioma cell survival and drug resistance is still unknown. Here we report that the NFIA pro-survival effect is mediated via
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4c8f7bf7c23bfa53ab50129d591bfb
https://doi.org/10.1093/neuonc/nox083.014
https://doi.org/10.1093/neuonc/nox083.014
Autor:
Hae-Ri Song, JunSung Lee
Glioblastoma (GBM) is the most common primary human malignant tumor and is almost incurable. Treatment of GBM is challenging, partly due to apoptosis evasion and drug resistance. We recently showed that Nuclear Factor I-A (NFIA), a glial fate determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa797dd7475614eb31321790658bbccf
https://europepmc.org/articles/PMC4217971/
https://europepmc.org/articles/PMC4217971/
Autor:
Hae-Ri Song, Tobias Abel, August Dietrich, Aram S. Modrek, Markus Schober, Moses V. Chao, Dimitris G. Placantonakis, Christian J. Buchholz, David Zagzag, Jonathan Lebowitz, N. Sumru Bayin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 12, p e116114 (2014)
PLoS ONE, Vol 9, Iss 12, p e116114 (2014)
Glioblastoma multiforme (GBM) is a deadly primary brain malignancy. Glioblastoma stem cells (GSC), which have the ability to self-renew and differentiate into tumor lineages, are believed to cause tumor recurrence due to their resistance to current t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3ba2f5de6acabb288d4ecb8a051ecb
https://pubmed.ncbi.nlm.nih.gov/25541984
https://pubmed.ncbi.nlm.nih.gov/25541984
Publikováno v:
Neuro-Oncology. :now233
Background The nuclear factor I-A (NFIA) transcription factor promotes glioma growth and inhibits apoptosis in glioblastoma (GBM) cells. Here we report that the NFIA pro-survival effect in GBM is mediated in part via a novel NFIA-nuclear factor-kappa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7293984128da7d77666dbcd6b1932c3
https://doi.org/10.1093/neuonc/now233
https://doi.org/10.1093/neuonc/now233